Earnings Feed
Start Free
Home/Filings/4/0001144204-10-053438
4//SEC Filing

HYPERTENSION DIAGNOSTICS INC /MN 4

Accession 0001144204-10-053438

CIK 0001058828operating
View on SEC.govCompany Profile

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 5:59 PM ET

Size

26.5 KB

Accession

0001144204-10-053438

Insider Transaction Report

Form 4
Period: 2010-10-01
HYPERTENSION DIAGNOSTICS INC /MNHDII
HOEKSTRA MARTEN
10% Owner
Transactions
  • Disposition to Issuer

    Preferred Stock Warrant

    2010-10-01−44,799→ 0 total
    Exercise: $3.60Exp: 2010-09-30→ Preferred Stock (44,799 underlying)
  • Award

    Preferred Stock Warrant

    2010-10-01+44,799→ 44,799 total
    Exercise: $3.60Exp: 2011-09-30→ Preferred Stock (44,799 underlying)
  • Disposition to Issuer

    Common Stock Warrant

    2010-10-01−407,105→ 0 total
    Exercise: $0.22Exp: 2010-09-30→ Common Stock (407,105 underlying)
  • Award

    Common Stock Warrant

    2010-10-01+712,433→ 712,433 total
    Exercise: $0.30Exp: 2011-09-30→ Common Stock (712,433 underlying)
  • Disposition to Issuer

    Preferred Stock Warrant

    2010-10-01−25,599.5→ 0 total
    Exercise: $2.64Exp: 2010-09-30→ Preferred Stock (25,599.5 underlying)
  • Award

    Common Stock Warrant

    2010-10-01+407,105→ 407,105 total
    Exercise: $0.22Exp: 2011-09-30→ Common Stock (407,105 underlying)
  • Award

    Preferred Stock Warrant

    2010-10-01+25,599.5→ 25,599.5 total
    Exercise: $2.64Exp: 2011-09-30→ Preferred Stock (25,599.5 underlying)
  • Disposition to Issuer

    Preferred Stock Warrant

    2010-10-05−44,799→ 0 total
    Exercise: $3.60Exp: 2011-09-30→ Preferred Stock (44,799 underlying)
  • Disposition to Issuer

    Common Stock Warrant

    2010-10-05−151,708→ 560,725 total
    Exercise: $0.30Exp: 2011-09-30→ Common Stock (151,708 underlying)
  • Disposition to Issuer

    Common Stock Warrant

    2010-10-01−712,433→ 0 total
    Exercise: $0.30Exp: 2010-09-30→ Common Stock (712,433 underlying)
Footnotes (8)
  • [F1]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in July 2010 the issuer extended the expiration date on all outstanding warrants of this type from September 30, 2010 to September 30, 2011. As a result, the reported transactions involve an amendment of outstanding warrants, resulting in the deemed cancellation of the "old" warrants and the grant of replacement warrants.
  • [F2]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in July 2010 the issuer extended the expiration date on all outstanding warrants of this type from September 30, 2010 to September 30, 2011. As a result, the reported transactions involve an amendment of outstanding warrants, resulting in the deemed cancellation of the "old" warrants and the grant of replacement warrants.
  • [F3]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in July 2010 the issuer extended the expiration date on all outstanding warrants of this type from September 30, 2010 to September 30, 2011. As a result, the reported transactions involve an amendment of outstanding warrants, resulting in the deemed cancellation of the "old" warrants and the grant of replacement warrants.
  • [F4]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in July 2010 the issuer extended the expiration date on all outstanding warrants of this type from September 30, 2010 to September 30, 2011. As a result, the reported transactions involve an amendment of outstanding warrants, resulting in the deemed cancellation of the "old" warrants and the grant of replacement warrants.
  • [F5]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in February 2010 the issuer temporarily modified the exercise price on all outstanding warrants of this type from $0.22 to $0.14. The issuer reported in the Form 10-K that such temporary price reduction is still in effect.
  • [F6]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in February 2010 the issuer temporarily modified the exercise price on all outstanding warrants of this type from $2.64 to $1.68. The issuer reported in the Form 10-K that such temporary price reduction is still in effect.
  • [F7]These warrants were assigned by the Reporting Person to the issuer for no value.
  • [F8]These warrants are immediately exercisable and remain exercisable until expiration.

Documents

1 file

Issuer

HYPERTENSION DIAGNOSTICS INC /MN

CIK 0001058828

→
Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0001058828

Filing Metadata

Form type
4
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 5:59 PM ET
Size
26.5 KB
View on SEC.gov